3SBio, Sponsored American Deposit Receipt News (NASDAQ:SSRX)
| Latest 3SBio, Sponsored American Deposit Receipt Representing 7 Shares News Headlines | | Date | Time | Source | | | 09/25/2008 | 8:00AM | PRNUS | 3SBio Inc. Files for SFDA Approval of High-dose (36,000 IU) EPIAO
SHENYANG, China, Sept. 25 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (NASDAQ:SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has filed with the Chinese State Food and Drug Administration (SFDA... More...>> |
| 09/16/2008 | 5:22PM | PRNUS | 3SBio Inc. to Present at the UBS Global Life Sciences Conference
SHENYANG, China, Sept. 16 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (NASDAQ:SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, announced that David Chen, Chief Operating Officer, will present at the UBS Global Life Sciences... More...>> |
| 08/25/2008 | 4:05PM | PRNUS | 3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
SHENYANG, China, Aug. 25 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (NASDAQ:SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, announces that David Chen, Chief Operating Officer will present at the Morgan Stanley Global... More...>> |
| 08/20/2008 | 4:05PM | PRNUS | 3SBio Inc. to Hold Annual General Meeting
SHENYANG, China, Aug. 20 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (NASDAQ:SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the 2008 Annual General Meeting of Shareholders of 3SBio Inc. will be held on... More...>> |
| 08/12/2008 | 4:10PM | PRNUS | 3SBio Inc. Announces Second Quarter 2008 Results
SHENYANG, China, Aug. 12 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (NASDAQ:SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results for the second quarter ended June 30, 2008.
Second... More...>> |
| 07/29/2008 | 4:05PM | PRNUS | 3SBio Inc. Schedules 2008 Second Quarter Earnings Release On Tuesday, August 12, 2008
Earnings Conference Call to be Held on August 13, 2008
at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm (Beijing/Hong Kong)
SHENYANG, China, July 29 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (NASDAQ:SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing... More...>> |
| 07/01/2008 | 8:30AM | PRNUS | 3SBio Inc. Announces Filing of Annual Report on Form 20-F
SHENYANG, China, July 1 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (NASDAQ:SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has filed with the SEC an annual report on Form 20-F for the year ended... More...>> |
| 05/28/2008 | 9:43AM | PRNUS | 3SBio Inc. to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
SHENYANG, China, May 28 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (NASDAQ:SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, announces that David Chen, Chief Operating Officer, and Kevin Teo, Chief Financial Officer will... More...>> |
| 05/27/2008 | 8:30AM | PRNUS | AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China
SHENYANG, China, May 28 /Xinhua-PRNewswire-FirstCall/ -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) and 3SBio, Inc. (NASDAQ:SSRX), a leading Chinese biotechnology company, today announced the signing of a development and commercialization agreement for ferumoxytol, an intravenous iron replacement therapeutic agent being... More...>> |
| 05/19/2008 | 9:20AM | PRNUS | 3SBio Inc. to Present at The Oppenheimer 2nd Annual China Dragon Call Conference
SHENYANG, China, May 19 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (NASDAQ:SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, will present at the Oppenheimer 2nd Annual China Dragon Call Conference in New York on Thursday... More...>> |
| 05/14/2008 | 4:30PM | PRNUS | 3SBio Inc. Announces First Quarter 2008 Results
- Q1 2008 net revenues grew 56.8%, as compared to Q1 2007, to RMB55.5
million (US$7.9 million)
- Q1 2008 operating income grew 22.4%, as compared to Q1 2007, to
RMB14.2 million (US$2.0 million)
- Q1 2008 net income grew 22.3%, as compared to Q1 2007, to RMB 19.8
million (US$2.8 million)
SHENYANG... More...>> |
| 04/29/2008 | 8:00AM | PRNUS | 3SBio Inc. Schedules 2008 First Quarter Earnings Release on Wednesday, May 14, 2008
Earnings Conference Call to be held on May 15, 2008 at 5:00 am (Pacific) /
8:00 am (Eastern) / 8:00 pm (Beijing/Hong Kong)
SHENYANG, China, April 29 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (NASDAQ:SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing... More...>> |
| 03/19/2008 | 4:35PM | PRNUS | 3SBio Inc. Announces Promotion of David Chen as Chief Operating Officer
SHENYANG, China, March 19 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (NASDAQ:SSRX) ('3SBio' or the 'Company'), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced the appointment of Dr. David Chen to the newly created... More...>> |
| 03/19/2008 | 4:30PM | PRNUS | 3SBio Inc. Approves Share Repurchase Program
SHENYANG, China, March 19 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (NASDAQ:SSRX) ("3SBio" or the "Company"), a leading, fully integrated, biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, announced today that its board of directors... More...>> |
| 02/20/2008 | 4:30PM | PRNUS | 3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results
- Q4 2007 net revenues grew 29.8%, as compared to Q4 2006, to RMB45.7
million (US$6.3 million)
- Q4 2007 net income grew 152.2%, as compared to Q4 2006, to RMB17.9
million (US$2.5 million)
- 2007 fiscal year net revenues increased 41.0% year-over-year to
RMB180.2 million (US$24.7 million)
- 2007... More...>> |
| 02/19/2008 | 4:30PM | PRNUS | 3SBio Inc. Announces Change to the Board of Directors
SHENYANG, China, Feb. 19 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (NASDAQ:SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that Mr. Mingde Yu has been appointed as an independent... More...>> |
| 01/30/2008 | 9:48AM | PRNUS | 3SBio Inc. to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
SHENYANG, China, Jan. 30 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (NASDAQ:SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, announces today that David Chen, VP of Business Development, will present at the Merrill Lynch Global... More...>> |
| 01/28/2008 | 4:05PM | PRNUS | 3SBio Inc. Announces Appointment of Kevin Sow Peng Teo as Chief Financial Officer
SHENYANG, China, Jan. 28 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (NASDAQ:SSRX) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced the appointment of Kevin Teo to the position of Chief Financial... More...>> |
| 11/20/2007 | 11:50AM | PRNUS | 3SBio Inc. To Present at the 19th Annual Piper Jaffray Health Care Conference
SHENYANG, China, Nov. 20 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (NASDAQ:SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, announces today that David Chen, VP of Business Development, will present at the 19th Annual Piper... More...>> |
| 11/13/2007 | 4:15PM | PRNUS | 3SBio Inc. Announces Third Quarter 2007 Results
SHENYANG, China, Nov. 13 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (NASDAQ:SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its financial results for the third quarter ended September 30, 2007.
Third Quarter... More...>> |
|
|
|